Last reviewed · How we verify
Darunavir and Cobicistat — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Darunavir and Cobicistat (Darunavir and Cobicistat) — Shanghai Public Health Clinical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Darunavir and Cobicistat TARGET | Darunavir and Cobicistat | Shanghai Public Health Clinical Center | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Darunavir and Cobicistat CI watch — RSS
- Darunavir and Cobicistat CI watch — Atom
- Darunavir and Cobicistat CI watch — JSON
- Darunavir and Cobicistat alone — RSS
Cite this brief
Drug Landscape (2026). Darunavir and Cobicistat — Competitive Intelligence Brief. https://druglandscape.com/ci/darunavir-and-cobicistat. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab